96 related articles for article (PubMed ID: 8336305)
1. Measurement of gold treatment effect in clinical practice: evidence for effectiveness of intramuscular gold therapy.
Wolfe F; Hawley DJ; Cathey MA
J Rheumatol; 1993 May; 20(5):797-802. PubMed ID: 8336305
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
[TBL] [Abstract][Full Text] [Related]
3. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
Pope JE; Khanna D; Norrie D; Ouimet JM
J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
[TBL] [Abstract][Full Text] [Related]
4. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?
Ward MM
J Rheumatol; 1994 Jan; 21(1):17-27. PubMed ID: 7864914
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
Wolfe F; Pincus T; O'Dell J
J Rheumatol; 2001 Jul; 28(7):1712-7. PubMed ID: 11469486
[TBL] [Abstract][Full Text] [Related]
6. The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.
Wolfe F; Hawley DJ
J Rheumatol; 1998 Nov; 25(11):2108-17. PubMed ID: 9818651
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.
Porter DR; Capell HA; Hunter J
J Rheumatol; 1993 Apr; 20(4):645-9. PubMed ID: 8496858
[TBL] [Abstract][Full Text] [Related]
8. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.
Yazici Y; Pincus T; Kautiainen H; Sokka T
J Rheumatol; 2004 Sep; 31(9):1723-6. PubMed ID: 15338490
[TBL] [Abstract][Full Text] [Related]
9. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.
Blackmore MG; Gladman DD; Husted J; Long JA; Farewell VT
J Rheumatol; 1995 May; 22(5):886-93. PubMed ID: 8587077
[TBL] [Abstract][Full Text] [Related]
10. Are patient self-report measures of arthritis activity confounded by mood? A longitudinal study of patients with rheumatoid arthritis.
Ward MM
J Rheumatol; 1994 Jun; 21(6):1046-50. PubMed ID: 7932413
[TBL] [Abstract][Full Text] [Related]
11. Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis.
van der Heide A; Jacobs JW; Schenk Y; Bijlsma JW
J Rheumatol; 1994 Dec; 21(12):2195-9. PubMed ID: 7699618
[TBL] [Abstract][Full Text] [Related]
12. The relationship between clinical activity and depression in rheumatoid arthritis.
Wolfe F; Hawley DJ
J Rheumatol; 1993 Dec; 20(12):2032-7. PubMed ID: 8014930
[TBL] [Abstract][Full Text] [Related]
13. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
Gordon P; West J; Jones H; Gibson T
J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
[TBL] [Abstract][Full Text] [Related]
14. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
[TBL] [Abstract][Full Text] [Related]
15. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
16. The longterm effect of pulsed corticosteroids on the efficacy and toxicity of chrysotherapy in rheumatoid arthritis.
Heytman M; Ahern MJ; Smith MD; Roberts-Thomson PJ
J Rheumatol; 1994 Mar; 21(3):435-41. PubMed ID: 8006886
[TBL] [Abstract][Full Text] [Related]
17. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy.
Fries JF; Williams CA; Singh G; Ramey DR
J Rheumatol; 1997 May; 24(5):838-44. PubMed ID: 9150069
[TBL] [Abstract][Full Text] [Related]
18. Functional Health Assessment Questionnaire (HAQ) and Psychological HAQ Are Associated with and Predicted by Different Factors in Rheumatoid Arthritis.
Verstappen SM; Jacobs JW; Huisman AM; van Rijthoven AW; Sokka T; Bijlsma JW
J Rheumatol; 2007 Sep; 34(9):1837-40. PubMed ID: 17787050
[TBL] [Abstract][Full Text] [Related]
19. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
Tsakonas E; Fitzgerald AA; Fitzcharles MA; Cividino A; Thorne JC; M'Seffar A; Joseph L; Bombardier C; Esdaile JM
J Rheumatol; 2000 Mar; 27(3):623-9. PubMed ID: 10743799
[TBL] [Abstract][Full Text] [Related]
20. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
